Spring is a miserable season for those with seasonal allergies. There are effective drug- and non-drug measures that can ...

Nasdepi® is a dry powder formulation of epinephrine being developed for intranasal administration to treat Type 1 allergic reactions including anaphylaxis. Nasdepi® remains to have the potential ...

Objective: Corticosteroids are effective in controlling the inflammatory component of allergic rhinitis; however, evidence for the clinical efficacy of systemic corticosteroids in this disease is ...

The timing of pollen, one of the three major causes of allergic rhinitis, has been accelerated. According to the revised pollen calendar recently released by the Korea Meteorological ...

whereas in chronic allergic disorders, such as vernal keratoconjunctivitis (VKC) or atopic keratoconjunctivitis (AKC), the mechanisms are more complex and probably involve both IgE and T-cell ...

A study led by Pompeu Fabra University reveals which brain mechanisms allow psychosis to ... The study examines differences in the neural connectivity patterns of patients who have recovered ...

The goal is to identify early risk factors for allergic rhinitis — such as environmental, lifestyle, or health-related factors — that we might be able to influence in order to prevent more people from ...

Some people may have an allergic reaction to Kisqali ... This is the drug’s mechanism of action (how it works). By blocking these proteins, Kisqali slows the cancer’s growth and helps prevent ...